The overall survival (OS) curves shown that the high expression of FUT2, IL1A, IL1B, IL17A, ITLN1, NAT2, PTGS2 and TP53 exhibited good prognosis of CRC patients (p < 0.05) (Fig. 1D). This evidence concerns the gene NAT2 and colorectal carcinoma.